NCT05078554 (HPV) is a clinical trial in Papilloma Viral Infection, sponsored by University Hospital, Strasbourg, France.

Who is sponsoring NCT05078554?

NCT05078554 is sponsored by University Hospital, Strasbourg, France.

What condition does NCT05078554 study?

NCT05078554 studies Papilloma Viral Infection.

Is NCT05078554 still recruiting?

NCT05078554 is currently completed. Last updated 10 September 2022.

Last reviewed 2022-09-10 · How we verify

NCT05078554: HPV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

HPV and Male Homosexuality in General Practice?

Completed Last updated 10 September 2022

What this trial tests

trial in Papilloma Viral Infection in 15 participants. Completed in 27 January 2022.

Timeline

27 May 2021

Primary endpoint
27 January 2022

27 January 2022

Quick facts

Lead sponsor	University Hospital, Strasbourg, France
Status	Completed
Study type	OBSERVATIONAL
Enrollment	15
Start date	27 May 2021
Primary completion	27 January 2022
Estimated completion	27 January 2022
Sites	1 location across France

Conditions studied

Papilloma Viral Infection — all drugs for Papilloma Viral Infection →

Sponsor

University Hospital, Strasbourg, France

Who can join

Adults 18 to 26, male only, with Papilloma Viral Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this study is to find out whether young MSM (men who have sex with men) believe it is important for their GP to be informed of their sexual orientation, in order to improve their clinical, especially with HPV vaccination. The secondary objective is to analyze the state of knowledge about the HPV vaccine and the value of HPV vaccine in this target population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Strasbourg, France trials

Trials by the same sponsor.

NCT07418554 — Sleep Disturbances in Children and Adolescents With Post-traumatic Stress Disorder (PTSD): a Randomized Double-blind Pla · Phase 3 · not yet recruiting
NCT07108582 — Reducing Chronic Pain After Lung Surgery: A Trial of Limiting NSAIDs During Recovery · Phase 3 · not yet recruiting
NCT07302646 — Optimizing Reduced-Flow, Low-Volume Contrast Protocols for Cerebral Angiography in Unruptured Aneurysms · NA · not yet recruiting
NCT07273968 — Clinical Study Evaluating the Effect of Virtual Reality on Reducing Patients' Anxiety During Wisdom Teeth Extraction · NA · not yet recruiting
NCT07214103 — Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulop · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05078554 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Strasbourg, France
Last refreshed: 10 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05078554.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing